Browse studies

Find your next paid study

56 recruiting studies matching your filters

Effects of Administration of Growth Hormone, Without and With Liraglutide, on AgRP, Energy and Glucose Metabolism in Healthy and GH Deficient Humans

This is a randomized, placebo-controlled, cross-over study with 4 arms. Healthy and GH deficient adults ages 18-45 years will be studied. Arms will consist of …

HealthyGrowth Hormone Deficiency

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Columbia UniversityNCT05681299

Phase 1

A Phase 1/2 Open-label Multicenter Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of GTAEXS617 in Patients With Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of GTAEXS617 (REC-617) in participants w…

Head and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Phase 2

Growth Hormone Replacement Therapy in Veterans With Gulf War Illness and Adult Growth Hormone Deficiency

The goal of the GWIT Study is to assess whether growth hormone replacement therapy is a safe and effective treatment for veterans with Gulf War Illness (GWI) a…

Gulf War SyndromeAdult Growth Hormone Deficiency

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Baylor College of MedicineNCT05355272

Phase 1

A Phase 1/2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of INX-315 in Patients With Advanced Cancer

Incyclix Bio (Incyclix) is developing INX-315 as an oral, small molecule inhibitor of cyclin dependent kinase 2 (CDK2) for the treatment of human cancers. This…

Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Incyclix BioNCT05735080

Phase 2

A Pilot Study of the Role of an Antimicrobial Herbal Formulation (Biocidin REMOVE) for the Management of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Irritable Bowel Syndrome (IBS)

The goal of this clinical trial is to learn if an herbal supplement called Biocidin REMOVE can clear small intestinal bacterial overgrowth (SIBO) in adults wit…

Irritable Bowel Syndrome (IBS)Small Intestinal Bacterial Overgrowth Syndrome (SIBO)

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Johns Hopkins UniversityNCT07768267

Tissue Oxygen Imager

The primary objective of this study is the evaluation of the efficacy of the tissue oxygen imager based on PpIX DF in differentiating benign skin growth from n…

Non-Melanoma Skin Cancer (NMSC)Benign Skin Growth

Estimated

~$10 – $750

Actual pay is set by the research site.

Dartmouth-Hitchcock Medical CenterNCT07201376

Phase 2

An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Exon 20 Insertion and Uncommon/Single or Compound Epidermal Growth Factor Receptor Mutations.

The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics (PK) of zipalertinib in participants with locally advanced or metastatic Non…

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Taiho Oncology, Inc.NCT05967689

Phase 1

A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and chang…

Hepatocellular CarcinomaPancreatic Ductal AdenocarcinomaBiliary Tract Cancers+5 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

AbbVieNCT06084481

Observational

Ovarian Platelet-Rich Plasma (oPRP) Injections Improvement In IVF Patients Based On Time-Lapse Incubator Culture for Automated Tracking and AI for Embryo Quality Assessment : A Non-Randomized Propsective Self-Controlled Interventional Study

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

InfertilityPoor Ovarian ReserveEmbryo Growth Disorder+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Generation Next FertilityNCT07020546

Phase 2

The OCEAN Trial: A Phase II Study of Osimertinib and Cyclosporine to Enhance Antitumor Efficacy in EGFR-Mutant Non-Small Cell Lung Cancer

This single-site, biomarker-enriched, randomized Phase II study will evaluate osimertinib with or without cyclosporine A (CsA) in metastatic epidermal growth f…

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor

Estimated

~$75 – $3,000

Actual pay is set by the research site.

NYU Langone HealthNCT07874490

Molecular Modulation of the Growth Plate

The researchers are trying to identify molecular mechanisms that control growth plate mediated limb growth and identify agents that can be used to enhance or s…

Growth Plate Injury

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT03501589

Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation

Optimal diagnostic management and underlying pathophysiological mechanisms of selective fetal growth restriction (sFGR) in monochorionic diamniotic (MCDA) twin…

Twin; Pregnancy, Affecting Fetus or NewbornFetal Growth RetardationTwin Monochorionic Diamniotic Placenta+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Leiden University Medical CenterNCT05952583